EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.82%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $36,692,651.16

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$44.37

▲ +0.36 (0.82%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/21/2025	Patrick J Haley	EVP	Sell	28,043	$42.58	$1,194,070.94	374,029
11/20/2025	Patrick J Haley	EVP	Sell	10,000	$42.11	$421,100.00	402,072
11/20/2025	Patrick J Haley	EVP	Sell	34,187	$41.88	$1,431,751.56
11/12/2025	Stelios Papadopoulos	Director	Sell	100,000	$43.55	$4,355,000.00	1,189,228
11/11/2025	Dana Aftab	EVP	Sell	48,383	$42.50	$2,056,277.50	664,778
11/11/2025	Mary C Beckerle	Director	Sell	24,622	$41.93	$1,032,400.46	21,380
6/3/2025	Jack L Wyszomierski	Director	Sell	7,535	$43.09	$324,683.15	358,882
6/2/2025	Sue Gail Eckhardt	Director	Sell	18,838	$42.74	$805,136.12	21,380
5/21/2025	Tomas J. Heyman	Director	Sell	4,544	$44.29	$201,253.76	32,470
5/20/2025	Patrick J Haley	EVP	Sell	34,387	$44.06	$1,515,091.22	412,072
5/16/2025	Amy C Peterson	CMO	Sell	72,776	$45.47	$3,309,124.72	465,393
5/16/2025	Christopher J Senner	CFO	Sell	100,000	$46.00	$4,600,000.00	967,842
5/16/2025	George Poste	Director	Sell	20,634	$45.99	$948,957.66	169,020
5/15/2025	Jeffrey J. Hessekiel	EVP	Sell	25,000	$46.18	$1,154,500.00	693,396
5/15/2025	Patrick J Haley	EVP	Sell	126,383	$47.96	$6,061,328.68	446,459
5/15/2025	Stelios Papadopoulos	Director	Sell	36,508	$44.35	$1,619,129.80	1,279,416
5/14/2025	Patrick J Haley	EVP	Sell	10,000	$42.68	$426,800.00	491,164
5/1/2025	Dana Aftab	EVP	Sell	1,508	$39.00	$58,812.00	693,181
3/3/2025	Patrick J Haley	EVP	Sell	10,000	$38.80	$388,000.00	341,028
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/28/2025	Jack L Wyszomierski	Director	Sell	8,768	$37.80	$331,430.40	356,605
2/25/2025	Bob Oliver	Director	Sell	18,647	$37.25	$694,600.75	33,514
2/24/2025	Christopher J Senner	CFO	Sell	29,314	$36.14	$1,059,407.96	779,607
2/24/2025	Patrick J Haley	EVP	Sell	52,636	$36.98	$1,946,479.28	303,310
2/14/2025	Mary C Beckerle	Director	Sell	12,210	$34.88	$425,884.80	30,406
11/29/2024	Jeffrey J. Hessekiel	EVP	Sell	60,000	$36.67	$2,200,200.00	486,059
11/22/2024	Patrick J Haley	EVP	Sell	10,000	$35.27	$352,700.00	278,665
11/18/2024	Patrick J Haley	EVP	Sell	41,588	$34.36	$1,428,963.68	288,665
11/5/2024	Dana Aftab	EVP	Sell	96,986	$35.00	$3,394,510.00	498,945
11/1/2024	George Poste	Director	Sell	30,000	$34.00	$1,020,000.00	169,020
11/1/2024	Jeffrey J. Hessekiel	EVP	Sell	50,000	$34.13	$1,706,500.00	530,325
10/30/2024	Dana Aftab	EVP	Sell	1,162	$31.40	$36,486.80	498,945
10/28/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$28.39	$709,750.00	580,325
9/23/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$26.38	$659,500.00	605,325
8/26/2024	Jeffrey J. Hessekiel	EVP	Sell	20,000	$25.79	$515,800.00	630,325
8/14/2024	Maria C. Freire	Director	Sell	8,250	$26.56	$219,120.00	91,007
8/12/2024	Dana Aftab	EVP	Sell	20,883	$27.06	$565,093.98	500,107
8/9/2024	Christopher J Senner	CFO	Sell	125,000	$27.19	$3,398,750.00	721,680
8/8/2024	George Poste	Director	Sell	33,725	$26.89	$906,865.25	199,020
8/7/2024	Dana Aftab	EVP	Sell	95,000	$25.00	$2,375,000.00	520,990
6/4/2024	Jack L Wyszomierski	Director	Sell	8,287	$22.00	$182,314.00	349,499
5/30/2024	David Edward Johnson	Director	Buy	225,000	$20.76	$4,671,000.00	1,525,730
5/28/2024	David Edward Johnson	Director	Buy	200,000	$20.32	$4,064,000.00	1,300,730
5/21/2024	George Poste	Director	Sell	11,686	$20.96	$244,938.56	213,907
5/13/2024	Jack L Wyszomierski	Director	Sell	10,923	$21.37	$233,424.51	338,948
3/21/2024	Alan M. Garber	Director	Sell	19,205	$24.01	$461,112.05	35,703
2/23/2024	Patrick J Haley	EVP	Sell	47,020	$21.45	$1,008,579.00	384,866
2/21/2024	David Edward Johnson	Director	Buy	190,000	$20.70	$3,933,000.00	1,100,730
12/14/2023	Patrick J Haley	EVP	Sell	50,000	$23.35	$1,167,500.00	307,687
12/12/2023	Patrick J Haley	EVP	Sell	14,149	$22.50	$318,352.50	307,687
12/4/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.06	$551,500.00	558,345
11/30/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.01	$550,250.00	583,345
11/27/2023	David Edward Johnson	Director	Buy	120,409	$21.61	$2,602,038.49	910,730
8/30/2023	Dana Aftab	EVP	Sell	4,600	$22.47	$103,362.00	399,943
8/3/2023	Christopher J Senner	CFO	Sell	60,000	$20.51	$1,230,600.00	571,631
8/3/2023	Patrick J Haley	EVP	Sell	30,553	$20.67	$631,530.51	285,467
8/1/2023	Jeffrey J. Hessekiel	EVP	Sell	55,710	$19.63	$1,093,587.30	571,976
4/5/2023	Jeffrey J. Hessekiel	EVP	Sell	38,930	$20.01	$778,989.30	582,435
3/10/2023	Jack L Wyszomierski	Director	Sell	15,300	$16.61	$254,133.00	317,467
3/1/2023	Jeffrey J. Hessekiel	EVP	Sell	77,860	$17.13	$1,333,741.80	527,716
2/27/2023	Dana Aftab	EVP	Sell	10	$17.50	$175.00	351,472
2/21/2023	Alan M. Garber	Director	Sell	40,000	$17.49	$699,600.00	31,417
2/9/2023	Carl B. Feldbaum	Director	Sell	40,000	$17.78	$711,200.00	18,701
2/6/2023	Patrick J Haley	EVP	Sell	25,000	$17.37	$434,250.00	254,414
12/15/2022	Peter Lamb	EVP	Sell	20,000	$15.88	$317,600.00	410,958

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

85.27% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/2/2025	Allworth Financial LP	2,869	$0.12M	0.0%	+72.0%	0.001%
12/2/2025	IFP Advisors Inc	48,320	$2M	0.1%	+20.7%	0.018%
12/2/2025	Swiss Life Asset Management Ltd	12,034	$0.50M	0.0%	+84.5%	0.004%
12/1/2025	Cambria Investment Management L.P.	23,434	$0.97M	0.1%	+20.4%	0.009%
11/24/2025	CIBC Private Wealth Group LLC	6,065	$0.25M	0.0%	+9.1%	0.002%
11/21/2025	CIBC Bancorp USA Inc.	8,639	$0.36M	0.0%	N/A	0.003%
11/20/2025	Centaurus Financial Inc.	3,751	$0.16M	0.0%	-39.8%	0.001%
11/19/2025	Center For Asset Management LLC	12,371	$0.51M	0.3%	N/A	0.005%
11/19/2025	Captrust Financial Advisors	75,293	$3.11M	0.0%	+6.4%	0.028%
11/19/2025	Danske Bank A S	236,045	$9.75M	0.0%	N/A	0.088%
11/18/2025	Advisory Services Network LLC	47,043	$1.94M	0.0%	+15.6%	0.018%
11/17/2025	Jacobs Levy Equity Management Inc.	472,820	$19.53M	0.1%	-53.1%	0.176%
11/17/2025	NewEdge Advisors LLC	26,351	$1.09M	0.0%	+17.0%	0.010%
11/17/2025	Krensavage Asset Management LLC	518,526	$21.42M	9.1%	+5.1%	0.193%
11/17/2025	CANADA LIFE ASSURANCE Co	231,451	$9.39M	0.0%	+6.1%	0.086%
11/17/2025	Caxton Associates LLP	13,323	$0.55M	0.0%	-45.8%	0.005%
11/17/2025	Woodline Partners LP	518,816	$21.43M	0.1%	-28.4%	0.194%
11/17/2025	American Trust	5,588	$0.23M	0.0%	+14.7%	0.002%
11/17/2025	Utah Retirement Systems	43,517	$1.80M	0.0%	-4.7%	0.016%
11/17/2025	Virtus Advisers LLC	13,000	$0.54M	0.4%	N/A	0.005%
11/17/2025	Voloridge Investment Management LLC	316,273	$13.06M	0.0%	N/A	0.118%
11/17/2025	Verition Fund Management LLC	17,924	$0.74M	0.0%	-85.2%	0.007%
11/17/2025	Tidal Investments LLC	68,412	$2.83M	0.0%	-13.9%	0.026%
11/17/2025	State Street Corp	11,114,815	$459.04M	0.0%	-2.4%	4.146%
11/17/2025	Sargent Investment Group LLC	194,210	$8.02M	1.1%	-4.9%	0.072%
11/17/2025	Shelton Capital Management	9,672	$0.40M	0.0%	-3.5%	0.004%
11/17/2025	Sherbrooke Park Advisers LLC	13,495	$0.56M	0.3%	-45.7%	0.005%
11/17/2025	Polymer Capital Management US LLC	7,986	$0.33M	0.0%	-31.4%	0.003%
11/17/2025	Public Employees Retirement System of Ohio	111,144	$4.59M	0.0%	+4.3%	0.041%
11/17/2025	Nomura Holdings Inc.	148,370	$6.13M	0.0%	+17.9%	0.055%
11/17/2025	Northwestern Mutual Wealth Management Co.	829	$34K	0.0%	+1,380.4%	0.000%
11/17/2025	Northern Trust Corp	2,281,277	$94.22M	0.0%	-1.4%	0.851%
11/17/2025	Mariner LLC	78,283	$3.23M	0.0%	+26.3%	0.029%
11/17/2025	Measured Wealth Private Client Group LLC	14,193	$0.59M	0.2%	+4.7%	0.005%
11/17/2025	National Bank of Canada FI	6,120	$0.25M	0.0%	-26.8%	0.002%
11/17/2025	Mercer Global Advisors Inc. ADV	69,420	$2.87M	0.0%	+8.0%	0.026%
11/17/2025	Millennium Management LLC	1,076,267	$44.45M	0.0%	+84.5%	0.401%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	28,992	$1.19M	0.0%	-21.4%	0.011%
11/17/2025	L2 Asset Management LLC	81,458	$3.36M	0.5%	N/A	0.030%
11/17/2025	Integrated Wealth Concepts LLC	11,174	$0.46M	0.0%	-22.4%	0.004%
11/17/2025	Hilltop Holdings Inc.	11,074	$0.46M	0.0%	N/A	0.004%
11/17/2025	Gotham Asset Management LLC	834,018	$34.45M	0.1%	-1.4%	0.311%
11/17/2025	Farallon Capital Management LLC	19,501,500	$805.41M	3.3%	+21.6%	7.274%
11/17/2025	Fred Alger Management LLC	145,999	$6.03M	0.0%	+2.0%	0.054%
11/17/2025	Focus Partners Wealth	144,802	$5.98M	0.0%	+263.5%	0.054%
11/17/2025	Brevan Howard Capital Management LP	16,882	$0.70M	0.0%	-74.8%	0.006%
11/17/2025	Capital Impact Advisors LLC	202,305	$8.36M	1.9%	+15.2%	0.075%
11/17/2025	Clark Capital Management Group Inc.	291,617	$12.04M	0.1%	+14.3%	0.109%
11/17/2025	California Public Employees Retirement System	525,569	$21.71M	0.0%	-0.2%	0.196%
11/17/2025	Anchor Investment Management LLC	600	$25K	0.0%	+500.0%	0.000%
11/17/2025	Algert Global LLC	21,779	$0.90M	0.0%	-84.4%	0.008%
11/17/2025	Alliancebernstein L.P.	349,050	$14.42M	0.0%	-5.3%	0.130%
11/17/2025	Allium Financial Advisors LLC	6,366	$0.26M	0.2%	-7.3%	0.002%
11/17/2025	Ameriprise Financial Inc.	659,805	$27.25M	0.0%	-8.7%	0.246%
11/14/2025	Creative Planning	110,523	$4.57M	0.0%	+26.5%	0.041%
11/14/2025	Lazard Asset Management LLC	297,435	$12.28M	0.0%	+13.4%	0.111%
11/14/2025	AQR Capital Management LLC	9,181,359	$379.19M	0.2%	+20.7%	3.424%
11/14/2025	Credit Agricole S A	45,046	$1.86M	0.0%	N/A	0.017%
11/14/2025	Raymond James Financial Inc.	942,381	$38.92M	0.0%	+6.3%	0.351%
11/14/2025	Bellevue Group AG	7,361	$0.30M	0.0%	-13.4%	0.003%
11/14/2025	Equitable Holdings Inc.	12,235	$0.51M	0.0%	N/A	0.005%
11/14/2025	Caisse de depot et placement du Quebec	2,724,564	$112.52M	0.2%	+28.0%	1.016%
11/14/2025	Exit Wealth Advisors LLC.	56,678	$2.34M	1.6%	N/A	0.021%
11/14/2025	Man Group plc	377,830	$15.60M	0.0%	+93.5%	0.141%
11/14/2025	California State Teachers Retirement System	245,864	$10.15M	0.0%	+3.6%	0.092%
11/14/2025	Horizon Investments LLC	56,381	$2.33M	0.0%	-43.6%	0.021%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	73,656	$3.04M	0.0%	+9.1%	0.027%
11/14/2025	Brooklyn Investment Group	5,466	$0.23M	0.0%	+38.8%	0.002%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	751,613	$31.04M	0.0%	-33.8%	0.280%
11/14/2025	Cim LLC	35,397	$1.46M	0.2%	+0.9%	0.013%
11/14/2025	Tower Research Capital LLC TRC	12,130	$0.50M	0.0%	+73.1%	0.005%
11/14/2025	Two Sigma Investments LP	39,309	$1.62M	0.0%	-93.9%	0.015%
11/14/2025	Bridgeway Capital Management LLC	81,650	$3.37M	0.1%	+26.2%	0.030%
11/14/2025	Vident Advisory LLC	150,816	$6.23M	0.1%	-11.0%	0.056%
11/14/2025	South Street Advisors LLC	426,181	$17.60M	2.3%	+127.9%	0.159%
11/14/2025	Harvest Fund Management Co. Ltd	2,728	$0.11M	0.0%	-87.3%	0.001%
11/14/2025	Prudential PLC	98,453	$4.07M	0.0%	-2.6%	0.037%
11/14/2025	Comerica Bank	75,558	$3.12M	0.0%	-12.9%	0.028%
11/13/2025	Vise Technologies Inc.	5,426	$0.22M	0.0%	-18.5%	0.002%
11/13/2025	Johnson Financial Group Inc.	3,708	$0.15M	0.0%	-7.9%	0.001%
11/13/2025	Arrowstreet Capital Limited Partnership	5,267,941	$217.57M	0.1%	+0.1%	1.965%
11/13/2025	Invesco Ltd.	5,960,525	$246.17M	0.0%	+7.1%	2.223%
11/13/2025	Sei Investments Co.	868,088	$35.85M	0.0%	-3.5%	0.324%
11/13/2025	BOKF NA	63,543	$2.62M	0.0%	-0.7%	0.024%
11/13/2025	UBS Group AG	2,655,069	$109.65M	0.0%	+100.1%	0.990%
11/13/2025	BNP Paribas Financial Markets	622,689	$25.72M	0.0%	+3.6%	0.232%
11/13/2025	Mackenzie Financial Corp	38,395	$1.59M	0.0%	-61.3%	0.014%
11/13/2025	Franklin Resources Inc.	1,295,684	$53.51M	0.0%	-4.4%	0.483%
11/13/2025	Van ECK Associates Corp	237,139	$9.79M	0.0%	+1.0%	0.088%
11/13/2025	Legal & General Group Plc	544,400	$22.48M	0.0%	-6.4%	0.203%
11/13/2025	Vestcor Inc	205,795	$8.50M	0.3%	+9.9%	0.077%
11/13/2025	Swiss National Bank	502,400	$20.75M	0.0%	+4.4%	0.187%
11/13/2025	Russell Investments Group Ltd.	544,261	$22.48M	0.0%	+10.9%	0.203%
11/13/2025	Schroder Investment Management Group	565,615	$22.95M	0.0%	-32.8%	0.211%
11/13/2025	Jefferies Financial Group Inc.	97,624	$4.03M	0.0%	+30.2%	0.036%
11/13/2025	Rathbones Group PLC	4,847	$0.20M	0.0%	-23.6%	0.002%
11/13/2025	Vinva Investment Management Ltd	22,964	$0.95M	0.0%	+57.6%	0.009%
11/13/2025	Parallel Advisors LLC	9,684	$0.40M	0.0%	-9.2%	0.004%
11/13/2025	Meiji Yasuda Asset Management Co Ltd.	6,255	$0.26M	0.0%	-4.4%	0.002%
11/13/2025	CreativeOne Wealth LLC	32,102	$1.33M	0.0%	+135.9%	0.012%

Data available starting January 2016

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $44.37

$43.95

$44.79

50 Day Range

MA: $40.60

$34.54

$44.37

52 Week Range

Now: $44.37

$31.90

$49.62

Volume

2,055,152 shs

Average Volume

2,450,766 shs

Market Capitalization

$11.90 billion

P/E Ratio

18.72

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
David Edward Johnson (Director)
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Patrick J Haley (EVP)
Amy C Peterson (CMO)
Jack L Wyszomierski (Director)
George Poste (Director)
Maria C Freire (Director)
Alan M Garber (Director)
Bob Oliver (Director)
Tomas J Heyman (Director)
Mary C Beckerle (Director)
Sue Gail Eckhardt (Director)
Learn More about top insider investors at Exelixis.
Who are the major institutional investors of Exelixis?: Exelixis' top institutional investors include:
Vanguard Group Inc. — 9.68%
Farallon Capital Management LLC — 7.27%
State Street Corp — 4.15%
AQR Capital Management LLC — 3.42%
LSV Asset Management — 2.89%
Invesco Ltd. — 2.22%
Learn More about top institutional investors of Exelixis stock.
Which major investors are selling Exelixis stock?: During the previous quarter, EXEL stock was sold by these institutional investors:
Vanguard Group Inc.
Pacer Advisors Inc.
Two Sigma Investments LP
Jacobs Levy Equity Management Inc.
First Trust Advisors LP
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
Citigroup Inc.
Schroder Investment Management Group
Within the previous year, company insiders that have sold Exelixis company stock include:
David Edward Johnson (Director)
Stelios Papadopoulos (Director)
Christopher J Senner (CFO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Patrick J Haley (EVP)
Amy C Peterson (CMO)
Jack L Wyszomierski (Director)
George Poste (Director)
Maria C Freire (Director)
Alan M Garber (Director)
Bob Oliver (Director)
Learn More investors selling Exelixis stock.
Which major investors are buying Exelixis stock?: In the previous quarter, EXEL stock was acquired by institutional investors including:
Farallon Capital Management LLC
Assetmark Inc.
AQR Capital Management LLC
Allianz Asset Management GmbH
UBS Group AG
Jupiter Asset Management Ltd.
Caisse de depot et placement du Quebec
Millennium Management LLC